Kubo N, Shirakawa O, Kuno T, Tanaka C
Jpn J Pharmacol. 1987 Mar;43(3):277-82. doi: 10.1254/jjp.43.277.
Quantitative evaluation of antimuscarinic effects of antihistamines (H1- and H2-receptor antagonists) was carried out using a receptor-binding assay. The -inhibition constants (Ki values) of twenty seven H1-receptor antagonists, one related antidepressant and three H2-receptor antagonists at H1-receptors and muscarinic receptors in the bovine cerebral cortex were determined. All the H2-receptor antagonists examined showed very low affinity for the muscarinic receptors. On the other hand, some H1-receptor antagonists (mequitazine, cyproheptazine, clemastine, diphenylpyraline, promethazine, homochlorcyclizine and alimemazine) had high affinity for the muscarinic receptors (Ki = 5.0-38 nM). Another group of H1-receptor antagonists (mepyramine, terfenadine, metapyrilen, azelastine, hydroxyzine and meclizine) had low affinity for the muscarinic receptors (Ki = 3,600-30,000 nM). Thus, a broad range of antimuscarinic potencies among the antihistamines was demonstrated. These results should provide helpful information with regard to the clinical and experimental use of antihistamines.
使用受体结合试验对抗组胺药(H1和H2受体拮抗剂)的抗毒蕈碱作用进行了定量评估。测定了27种H1受体拮抗剂、1种相关抗抑郁药和3种H2受体拮抗剂在牛大脑皮层H1受体和毒蕈碱受体上的抑制常数(Ki值)。所有检测的H2受体拮抗剂对毒蕈碱受体的亲和力都非常低。另一方面,一些H1受体拮抗剂(美喹他嗪、赛庚啶、氯马斯汀、二苯拉林、异丙嗪、氯环利嗪和阿利马嗪)对毒蕈碱受体具有高亲和力(Ki = 5.0 - 38 nM)。另一组H1受体拮抗剂(吡苄明、特非那定、间吡拉敏、氮卓斯汀、羟嗪和氯苯甲嗪)对毒蕈碱受体的亲和力较低(Ki = 3600 - 30000 nM)。因此,证明了抗组胺药之间存在广泛的抗毒蕈碱效力范围。这些结果应为抗组胺药的临床和实验应用提供有用信息。